# Shire Regenerative Medicine

- Location (FDA's records): San Diego
- FDA decisions: 2 (1997–2001): 2 original PMA approvals
- Product codes: MGR (2)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- P000036: Dermagraft (Sep 28, 2001)
- P960007: Transcyte Human Fibroblast-Derived Temporary Skin Substitute (Mar 18, 1997)

Source page: https://510kreport.com/company/shire-regenerative-medicine